Cooper Creek Partners Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Cooper Creek Partners Management’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-79,510	Closed	-$1.45M	–	151
2021 Q4	$1.45M	Hold	79,510	–	–	0.17%	99
2021 Q3	$942K	Sell	79,510 -9,690	-11%	-$141K	0.13%	98
2021 Q2	$1.53M	Hold	89,200	–	–	0.39%	89
2021 Q1	$1.63M	Hold	89,200	–	–	0.46%	74
2020 Q4	$1.68M	Hold	89,200	–	–	0.42%	81
2020 Q3	$1.88M	Hold	89,200	–	–	0.47%	71
2020 Q2	$2.58M	Buy	+89,200	New	+$2.69M	0.67%	53

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cooper Creek Partners Management's OYST Position: Q1 2022 in Review

Cooper Creek Partners Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2022, closing a stake of 79,510 shares — an estimated $1.45M sold.

Cooper Creek Partners Management first reported a position in OYST in Q2 2020 and held it in 7 quarters. The position peaked at $2.58M in Q2 2020. 72 funds tracked by Wall St. Rank hold OYST as of Q1 2022.

Cooper Creek Partners Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Cooper Creek Partners Management sold 79,510 Oyster Point Pharma, Inc. Common Stock shares in Q1 2022, an estimated $1.45M.
Cooper Creek Partners Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
Cooper Creek Partners Management's Oyster Point Pharma, Inc. Common Stock position peaked at $2.58M in Q2 2020.
72 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2022.

Based on Cooper Creek Partners Management's 13F filing for Q1 2022, filed 16 May 2022.